In the first episode of On Trial, a podcast dedicated to the art of trial, host Christopher DeGennaro, a commercial litigator at Foley & Lardner LLP in New York sits down with Foley senior partner Peter Wang, a legendary New York trial lawyer with nearly 50 years of experience. In addition to offering his thoughts on an effective opening statement, the most important part of a trial in his view, Peter shares some of his trial rituals and most memorable trial moments.
Listen to On Trial episode 1 below or listen and subscribe on Apple Podcasts, Google Podcasts, Spotify, or Stitcher.
Disclaimer
This podcast is provided for general informational purposes only and is intended as a general overview. The podcast does not constitute legal advice nor solicitation to provide legal services. It is not meant to convey a legal position of Foley & Lardner, LLP (“Foley” or the “Firm”) on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this podcast do not necessarily reflect the views of the Firm, its partners, or its clients. The podcast is not intended to create, and listening to the podcast does not constitute an attorney-client relationship. The listener should not act upon this information without seeking counsel from a licensed attorney. Foley makes no representations or warranties of any kind, express or implied, as to the content of the podcast or to its accuracy or completeness and accepts no responsibility for an individual who acts or refrains from acting based on information obtained from the podcast. In some jurisdictions, the contents of this podcasts may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome.
Speaker(s)
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.